Emergency Medicine Continuing Medical Education

Episodes 17-32 of 42

Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
MinuteCE®
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
1.75 program credits
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
MinuteCE®
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
1.75 program credits
- Scott Kaatz, DO, MSc, FACP, SFHM
1.75 program credits
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
MinuteCE®
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
1.75 program credits
- Deborah Siegal, MD, MSc, FRCPC
1.75 program credits
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
MinuteCE®
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
1.75 program credits
- Deborah Siegal, MD, MSc, FRCPC
1.75 program credits
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
MinuteCE®
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
1.75 program credits
- Alfonso J. Tafur, MD, MS, MBA, RPVI
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
MinuteCE®
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
1.75 program credits
- Scott Kaatz, DO, MSc, FACP, SFHM
1.75 program credits
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
MinuteCE®
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
1.75 program credits
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
Right from the Onset: PE Diagnosis, Management
Right from the Onset: PE Diagnosis, Management
MinuteCE®
Right from the Onset: PE Diagnosis, Management
1.75 program credits
- Bruce L. Davidson, MD, MPH
1.75 program credits
Right from the Onset: DVT Diagnosis, Management
Right from the Onset: DVT Diagnosis, Management
MinuteCE®
Right from the Onset: DVT Diagnosis, Management
1.75 program credits
- Bruce L. Davidson, MD, MPH
1.75 program credits
MinuteCE®
Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma
1.00 credit 10 episodes
- Sagar Lonial, MD, FACP
- Caitlin Costello, MD
1.00 credit 10 episodes
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
MinuteCE®
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
1.00 program credit
- Sagar Lonial, MD, FACP
- Caitlin Costello, MD
1.00 program credit
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
MinuteCE®
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
1.00 program credit
- Sagar Lonial, MD, FACP
- Caitlin Costello, MD
1.00 program credit
Efficacy Data for Bispecific Antibodies in RRMM
Efficacy Data for Bispecific Antibodies in RRMM
MinuteCE®
Efficacy Data for Bispecific Antibodies in RRMM
1.00 program credit
- Sagar Lonial, MD, FACP
1.00 program credit
Considerations for Dosing Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
MinuteCE®
Considerations for Dosing Bispecific Antibodies
1.00 program credit
- Sagar Lonial, MD, FACP
- Caitlin Costello, MD
1.00 program credit
Clinical Challenges With Triple-Class or Penta-Refractory MM
Clinical Challenges With Triple-Class or Penta-Refractory MM
MinuteCE®
Clinical Challenges With Triple-Class or Penta-Refractory MM
1.00 program credit
- Sagar Lonial, MD, FACP
- Caitlin Costello, MD
1.00 program credit
Integrating Bispecific Antibodies Into Clinical Practice
Integrating Bispecific Antibodies Into Clinical Practice
MinuteCE®
Integrating Bispecific Antibodies Into Clinical Practice
1.00 program credit
- Sagar Lonial, MD, FACP
- Caitlin Costello, MD
1.00 program credit

2/3